{"id":6471,"date":"2023-01-04T15:53:00","date_gmt":"2023-01-04T06:53:00","guid":{"rendered":"https:\/\/hbio.jp\/news\/?p=6471"},"modified":"2024-08-21T15:54:14","modified_gmt":"2024-08-21T06:54:14","slug":"20230104","status":"publish","type":"post","link":"https:\/\/hbio.jp\/news\/en\/2023\/01\/04\/20230104\/","title":{"rendered":"World’s First Early Pancreatic Cancer Test “N-NOSE plus Pancreas”"},"content":{"rendered":"

HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as \u201cHIROTSU\u201d)), will start the actual testing of the world’s first early pancreatic cancer test “N-NOSE plus Pancreas,” developed as the first test of the next-generation “cancer type-specific test” derived from the nematode cancer test “N-NOSE.” We have received more applications than expected during the approximately one-month pre-order period, reflecting our customers’ strong desire for early detection of pancreatic cancer. Our company remains committed to research and development to create a future where cancer is no longer feared, and to provide reassurance to many through high-precision testing.<\/strong><\/p>\n\n\n\n

Our company has succeeded in developing “N-NOSE plus Pancreas,” the first next-generation “cancer type-specific” test of “N-NOSE\u00ae” primary cancer screening, and will begin actual testing this year. “Pancreatic cancer” is considered the most difficult to detect and treat among cancers, and the medical community has regarded the development of an early pancreatic cancer test as revolutionary. By leveraging the excellent capabilities of biological organisms and the fusion of biotechnology, we aim to use this test to save as many lives as possible.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Overview of “N-NOSE plus Pancreas”
<\/span>Testing Start (Test Kit Shipment): From January 4, 2023 (Wednesday)
Sales Website: https:\/\/lp.n-nose.com\/suizou\/<\/a>
Testing Fee: Regular price \u00a570,000 (including tax). For those who have taken “N-NOSE\u00ae” within three months, the price is \u00a550,000 (including tax).<\/p>\n\n\n\n

Download PDF<\/a><\/p>","protected":false},"excerpt":{"rendered":"

HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referre […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/hbio.jp\/news\/?p=6471","footnotes":""},"categories":[3],"tags":[],"class_list":["post-6471","post","type-post","status-publish","format-standard","hentry","category-press-release","en-US"],"acf":[],"_links":{"self":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/6471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/comments?post=6471"}],"version-history":[{"count":1,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/6471\/revisions"}],"predecessor-version":[{"id":6472,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/posts\/6471\/revisions\/6472"}],"wp:attachment":[{"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/media?parent=6471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/categories?post=6471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hbio.jp\/news\/en\/wp-json\/wp\/v2\/tags?post=6471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}